SKYE Stock Analysis: Buy, Sell, or Hold?
SKYE - Skye Bioscience, Inc. Common Stock
$0.61
-0.02 (-2.42%)
▼
5d:
-13.93%
30d:
-23.13%
90d:
-25.77%
HOLD
MODERATE Confidence
Analysis Updated: Jul 15, 2026 12:00 AM ET
Earnings: Aug 06, 2026
21d
Get Alerted When SKYE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: SKYE shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: SKYE shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: SKYE is currently trading at $0.61, which is considered oversold relative to its 30-day fair value range of $0.66 to $0.75.
Technical Outlook: Technically, SKYE is showing sideways momentum. The price is currently testing key support at $0.68. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: SKYE has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $7.71 (+1144.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SKYE is showing sideways momentum. The price is currently testing key support at $0.68. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: SKYE has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $7.71 (+1144.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.66 -
$0.75
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 1144.0% below Wall St target ($7.71)
- CAUTION: 5-day price weakness (-13.9%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$0.66 -
$0.75
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.68
Resistance Level
$0.86
Current Trend
Sideways
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.55
Wall Street Target
$7.71
(+1144.0%)
Share & Embed Analysis
Last updated: July 15, 2026 3:26 PM ET
Data refreshes hourly during market hours. Next update: 4:26 PM
Data refreshes hourly during market hours. Next update: 4:26 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SKYE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$26 | 55 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$413 | 57 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 58 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$122 | 54 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 59 HOLD |
